projects:workgroups:clinicalstudy
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
projects:workgroups:clinicalstudy [2021/06/29 15:38] mikehamidi |
projects:workgroups:clinicalstudy [2021/09/04 11:38] zhen |
||
|---|---|---|---|
| Line 5: | Line 5: | ||
| **Objective**: To allow adequate representation of clinical trial data in OMOP. | **Objective**: To allow adequate representation of clinical trial data in OMOP. | ||
| - | **First use case**: To convert clinical trial data in CDISC SDTM format to OMOP, with a view to allowing trial planning optimization. | + | **First use case**: To convert clinical trial data in [[https://www.cdisc.org/standards/foundational/sdtm|CDISC SDTM]] format to [[https://www.ohdsi.org/data-standardization/the-common-data-model/|OMOP]], with a view to allowing trial planning optimization. |
| **Approach**: We advocate minimum changes to the OMOP CDM and Standardized Vocabularies because we want to ensure minimum impact on OHDSI tools like Atlas, whilst providing a value-add SDTM-to-OMOP conversion with minimum data loss. We have proposed conventions introducing new concepts and modifiers, but no new CDM tables; and providing guidance for ETL developers where appropriate. Our proposals are built on OMOP CDM v6 and the Oncology extension, with v5.3.1 backward compatibility. | **Approach**: We advocate minimum changes to the OMOP CDM and Standardized Vocabularies because we want to ensure minimum impact on OHDSI tools like Atlas, whilst providing a value-add SDTM-to-OMOP conversion with minimum data loss. We have proposed conventions introducing new concepts and modifiers, but no new CDM tables; and providing guidance for ETL developers where appropriate. Our proposals are built on OMOP CDM v6 and the Oncology extension, with v5.3.1 backward compatibility. | ||
| Line 16: | Line 16: | ||
| - | ==== Membership ==== | ||
| - | |||
| - | **WG co-leads**: | ||
| - | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|Mike Hamidi]], Pfizer, US (Kamiar.Hamidi@pfizer.com) | ||
| - | [[https://www.linkedin.com/in/zhen-lin/|Zhen Lin]], Robot Bacon, US (Zhen.Lin@ohdsi.org) | ||
| - | |||
| - | |||
| - | **Current members**\\ | ||
| - | {{:projects:workgroups:currentmembers_june_2021_v2_.png?600|}} | ||
| - | ---- | ||
| ==== Important Links ==== | ==== Important Links ==== | ||
| Line 40: | Line 30: | ||
| **Schedule**: | **Schedule**: | ||
| - | Biweekly calls on Fridays, 7AM PT/9AM CT/10AM ET/3PM UK time on Teams [[https://teams.microsoft.com/l/channel/19%3acc614694401a40b4b48668bd271cc9c0%40thread.tacv2/General?groupId=176311d3-ef0e-467c-bf6f-47c7f3aa82a0&tenantId=a30f0094-9120-4aab-ba4c-e5509023b2d5|here]] | + | Biweekly calls on Fridays, 7:30AM PT/9:30AM CT/10:30AM ET/3:30PM UK time on Teams [[https://teams.microsoft.com/l/channel/19%3acc614694401a40b4b48668bd271cc9c0%40thread.tacv2/General?groupId=176311d3-ef0e-467c-bf6f-47c7f3aa82a0&tenantId=a30f0094-9120-4aab-ba4c-e5509023b2d5|here]] |
| //**Note on accessing Teams channel above:**\\ | //**Note on accessing Teams channel above:**\\ | ||
| * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | ||
| * Alternatively, select the "web app" button in the link above for accessing meetings on your browser// | * Alternatively, select the "web app" button in the link above for accessing meetings on your browser// | ||
| + | |||
| + | ---- | ||
| + | |||
| + | ==== Membership ==== | ||
| + | |||
| + | **WG co-leads**: | ||
| + | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|Mike Hamidi]], Pfizer, US (Kamiar.Hamidi@pfizer.com) | ||
| + | [[https://www.linkedin.com/in/zhen-lin/|Zhen Lin]], Robot Bacon, US (Zhen.Lin@ohdsi.org) | ||
| + | |||
| + | |||
| + | **Active members**\\ | ||
| + | |||
| + | ^ Name ^ Organization ^ Location ^ ^ | ||
| + | | Rebecca Baker | CDISC | Austin, Texas, USA | | | ||
| + | | Mike Hamidi | Pfizer | USA | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|L]] | | ||
| + | | Michael Kallfelz | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| + | | Zhen Lin | Robot Bacon | Houston, TX, USA | [[https://www.linkedin.com/in/zhen-lin/|L]], [[https://twitter.com/zhenLinPhDRN|T]] | | ||
| + | | Katy Sadowski | TrialSpark | New York, NY, USA | | | ||
| + | | Philip Solovyev | Odysseus Data Services Inc. | Cambridge, MA, USA | | | ||
| + | | Anthony Sunjaya | The George Institute for Global Health, UNSW Sydney | Sydney, NSW, Australia | | | ||
| + | | Tom Walpole | Trials.ai | San Diego, CA, USA | | ||
| + | | Ariana Winder | REDCap Cloud | Bellefonte, PA, USA | [[https://www.linkedin.com/in/amwinder/|L]] | | ||
| + | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | ||
| + | |||
| + | ---- | ||
| + | |||
| + | **Other members**\\ | ||
| + | |||
| + | ^ Name ^ Organization ^ Location | ||
| + | | Eldar Allakhverdiiev | Odysseus Data Services Inc. | Cambridge, MA, USA| ^ | ||
| + | | Sonia Araujo * | IQVIA | London, UK | | ||
| + | | Ted Bebi | Medidata | Boston, MA, USA | | ||
| + | | Lina Clover | SAS | Raleigh-Durham, NC, USA | | ||
| + | | Alexander Davydov | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| + | | Shawn Dolley | Open Global Health | Arlington, Virginia, USA | | ||
| + | | Rhonda Facile | CDISC | Austin, Texas, USA | | ||
| + | | Vojtech Huser | National Library of Medicine, National Institutes of Health | Bethesda, MD, USA | | ||
| + | | Gregory Klebanov | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| + | | Bess LeRoy | CDISC | Tucson, AZ, USA | | ||
| + | | James Liddil | M2Gen | Tampa, FL, USA | | ||
| + | | Asiyah Yu Lin | National Institute of Health | Bethesda, Maryland, USA | | ||
| + | | Maxim Moinat | The Hyve | Utrecht, The Netherlands | | ||
| + | | Alexandra Orlova | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| + | | Joshua F. Ransom | BEKHealth Inc | Wayland, MA, USA | | ||
| + | | Chris Roeder | School of Medicine, University of Colorado | CO, USA | | ||
| + | | Cynthia Sung| Bill & Melinda Gates Medical Research Institute | Seattle, WA, USA| | ||
| + | | Emma Vos | The Hyve | Utrecht, The Netherlands| | ||
| + | | Andrew Williams | Tufts Institute for Clinical Research and Health Policy Studies | Boston, MA, USA | | ||
| + | |||
| + | * Past leads | ||
| ---- | ---- | ||
projects/workgroups/clinicalstudy.txt ยท Last modified: 2024/04/28 20:17 by zhen
Page Tools
